• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER AMULET; CARDIAC PLUG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER AMULET; CARDIAC PLUG Back to Search Results
Catalog Number 9-ACP2-007-022
Device Problems Improper or Incorrect Procedure or Method (2017); Patient-Device Incompatibility (2682)
Patient Problems Perforation (2001); Pericardial Effusion (3271)
Event Date 11/17/2023
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2023, a 22mm amplatzer amulet left atrial appendage occluder was chosen for implant, with a 12f amplatzer torqvue 45x45 delivery sheath.Pre-procedural transesophageal echocardiography (tee) noted, the patient had baseline pericardial effusion with fluid noted, around the left ventricle.During procedure, it was noted, the patient's activated clotting time (act) levels were 257 seconds and the patient was administered 7k of heparin.It was reported, the patient had a thick lipomatous septum that made the transseptal puncture difficult and required a second puncture.Device preparation was followed, per instructions for use (ifu) with no air noted.During the first deployment attempt, the location was not acceptable and the device was recaptured into the ball formation.The device was then advanced forward, but in "spearlike" position and proctoring.Physician stopped operating to readjust the device back into ball position.After device deployment, perforation was noted.And fluid was also noted, in the left atrial appendage.The operating physician proceeded with device deployment to stop the effusion in the left atrial appendage.A decision then made to perform a pericardiocentesis and 500cc of blood was drained.Reversal agent, protamine, was administered to reverse heparin.The patient's blood pressure was stabilized.And transferred to intensive care unit (icu) for recovery.The patient status was reported stable and discharged to home.
 
Manufacturer Narrative
An event of perforation and fluid noted in the left atrial appendage after deployment was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.It was reported the patient had a thick lipomatous septum that made the transseptal puncture difficult and required a second puncture, this difficulty may have contributed to the reported event.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.Please note that per the instructions for use, "if device repositioning is required: partially recapture the device by maintaining tension on the delivery cable and readvancing the delivery sheath to retrieve the disc and part of the lobe until the platinum thread marker is aligned with the distal edge of the delivery sheath¿s marker band (see figure 4).Do not retract the device any farther to prevent damaging the delivery sheath.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER AMULET
Type of Device
CARDIAC PLUG
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18322747
MDR Text Key330428076
Report Number2135147-2023-05494
Device Sequence Number1
Product Code NGV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P200049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number9-ACP2-007-022
Device Lot Number8816670
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/13/2023
Supplement Dates Manufacturer Received12/15/2023
Supplement Dates FDA Received01/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMPLATZER TORQVUE 45X45 DS, 9-TV45X45-12F-080
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient SexMale
-
-